Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular and Rilpivirine

• Generic Name: pneumococcal 13-valent vaccine
• Dosage Forms: n.a.
• Other Brand Names: Prevnar 13

Pneumococcal 13-valent diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by pneumococcal bacteria. It works by causing your body to produce its own protection (antibodies) against the disease.

Pneumococcal infection can cause serious problems, such as pneumonia, which affects the lungs; meningitis, which affects the brain; and bacteremia, which is a severe infection in the blood. Pneumococcal infection is also an important cause of ear infections in children.

Unless otherwise contraindicated, immunization (vaccination) against pneumococcal disease is recommended for infants and young children 6 weeks to 5 years of age (prior to the 6th birthday), children 6 to 17 years of age (prior to the 18th birthday), or to adults 18 years of age and older.

For infants and young children, immunization requires 1 to 4 doses of the vaccine, depending on the age at the first dose. This vaccine can be given at the same time as other routine vaccinations.

This vaccine is to be given only by or under the supervision of your doctor.

• Generic Name: rilpivirine
• Dosage Forms: n.a.
• Other Brand Names: Edurant

Rilpivirine is an antiviral medicine that prevents human immunodeficiency virus (HIV) from multiplying in your body.

Rilpivirine is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). Rilpivirine is not a cure for HIV or AIDS. Rilpivirine is for use in adults and children who are at least 12 years old weighing at least 77 pounds (35 kilograms).

Rilpivirine must be used in combination with other HIV medicines your doctor has prescribed.

Rilpivirine may also be used for purposes not listed in this medication guide.